Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q3 2018 · 10-Q
Revenue$0.00$0.00— vs Q3 2017 Net Income-$87.74M-$87.74MN/M vs Q3 2017 EPS Diluted-$1.14-$1.14N/M vs Q3 2017 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
-$83,983,000
N/M
Operating Cash Flowderived-$65,488,000N/M Free Cash Flowderived-$67,339,000N/M ended Sep 30, 2018 · filed Oct 30, 2018 · 30 d after period end